These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19335716)

  • 1. Soy constituents: modes of action in low-density lipoprotein management.
    van Ee JH
    Nutr Rev; 2009 Apr; 67(4):222-34. PubMed ID: 19335716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients.
    Imani H; Tabibi H; Atabak S; Rahmani L; Ahmadinejad M; Hedayati M
    J Ren Nutr; 2009 Sep; 19(5):389-95. PubMed ID: 19577483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering mechanism of soybean protein hydrolysate.
    Cho SJ; Juillerat MA; Lee CH
    J Agric Food Chem; 2007 Dec; 55(26):10599-604. PubMed ID: 18052124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient at risk: who should we be treating?
    Leitersdorf E
    Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy, phytoestrogens and metabolism: A review.
    Cederroth CR; Nef S
    Mol Cell Endocrinol; 2009 May; 304(1-2):30-42. PubMed ID: 19433245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy and the prevention of lifestyle-related diseases.
    Zhou JR
    Clin Exp Pharmacol Physiol; 2004 Dec; 31 Suppl 2():S14-9. PubMed ID: 15649276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of lifestyle modification on a new oxidized low-density lipoprotein marker, serum amyloid A-LDL, in subjects with primary lipid disorder.
    Kotani K; Koibuchi H; Yamada T; Taniguchi N
    Clin Chim Acta; 2009 Nov; 409(1-2):67-9. PubMed ID: 19723514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I'm trying to keep my cholesterol down, so I've been eating soy burgers in place of hamburgers. Now I hear that soy may not have much effect on cholesterol. Can I go back to the real thing?
    Mayo Clin Health Lett; 2006 Jun; 24(6):8. PubMed ID: 16832855
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiatherogenic and antiperoxidative effects of garlic and soy proteins in alcohol fed rats.
    Rajasree CR; Rajmohan T; Augusti KT
    Indian J Exp Biol; 2009 Mar; 47(3):169-75. PubMed ID: 19405381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy: a complete source of protein.
    Michelfelder AJ
    Am Fam Physician; 2009 Jan; 79(1):43-7. PubMed ID: 19145965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoflavonoid content of Hong Kong soy foods.
    Chan SG; Murphy PA; Ho SC; Kreiger N; Darlington G; So EK; Chong PY
    J Agric Food Chem; 2009 Jun; 57(12):5386-90. PubMed ID: 19530716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature.
    Beavers KM; Jonnalagadda SS; Messina MJ
    Nutr Rev; 2009 Apr; 67(4):213-21. PubMed ID: 19335715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Healthier thanks to soy products?].
    Praxis (Bern 1994); 2004 May; 93(20):887. PubMed ID: 15195840
    [No Abstract]   [Full Text] [Related]  

  • 20. Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention.
    Grundy SM
    Circulation; 2008 Jan; 117(4):569-73; discussion 573. PubMed ID: 18227397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.